Sage Journals: Discover world-class research

Abstract

Crystalloids are generally accepted, as the initial fluid of choice during trauma patient resuscitation but the pragmatic approach is to give a combination of both crystalloid and colloid. Plasmalyte 148 has advantages over both saline and lactated Ringer’s. Medium-or low-molecular weight hydroxyethyl starch may be the colloid of choice. In the future, haemoglobin-based oxygen carriers are likely to play a prominent role in trauma resuscitation.

Keywords

fluids resuscitation trauma crystalloids colloids haemoglobin-based oxygen carriers

Get full access to this article

View all access options for this article.

References

Agarwal N , Murphy JG , Gayten CG et al. 1993. Blood transfusion increases the risk of infection after trauma. Arch Surg 128: 171-177.

Alderson P , Schierhout G , Roberts I et al. 2000. Colloids versus crystalloids for fluid resuscitation in critically ill patients. Cochrane Database Syst Rev (2): CD000567.

Allison KP , Gosling P , Jones S et al. 1999. Randomised trial of hydroxyethyl starch versus gelatine for trauma resuscitation. J Trauma 47: 1114-1121.

American College of Surgeons Committee on Trauma . 1997. Advanced Trauma Life Support® for doctors student course manual. Chicago, American College of Surgeons.

Arfors KE , Buckley PB. 1997. Pharmacological characteristics of artificial colloids. Baillière’s Clin Anaesth 11: 15-47.

Bock JC , Barker BC , Clinton AG et al. 1989. Post-traumatic changes in, and effect of colloid osmotic pressure on the distribution of body water. Ann Surg 210: 395-405.

Boldt J , Heeson M , Muller M et al. 1996. The effects of albumin versus hydroxyethyl starch solution on cardiorespiratory and circulatory variables in critically ill patients. Anesth and Analg 83: 254-261.

Bothner U , Georgieff M , Vogt NH. 1998. Assessment of the safety and tolerance of 6% hydroxyethyl starch (200/0.5) solution: a randomised, controlled epidemiology study. Anesth Analg 86: 850-855.

Carmichael FJL. 2001. Recent developments in hemoglobin-based oxygen carriers - an update on clinical trials. Trans Apheresis Sci 24: 17-21.

10.

Choi PTL , Yip G , Quinonez LG et al. 1999. Crystalloids vs. colloids in fluid resuscitation: a systematic review. Crit Care Med 27: 200-210.

11.

Cochrane Injuries Group Albumin Reviewers . 1998. Human albumin administration in critically ill patients: systematic review of randomised controlled trials. Br Med J 317: 235-240.

12.

Cohn SM. 1997. Is blood obsolete? J Trauma 42: 730-732.

13.

Conhaim RL , Harms BA. 1998. Hemoglobin therapeutics in hemorrhagic shock. Curr Opin Crit Care 4: 442-446.

14.

Cooper DJ , Murray L. 2001. Hypertonic resuscitation for traumatic brain injury? In: Vincent J-L ed. Yearbook of intensive care and emergency medicine. Berlin: Springer: 342-352.

15.

Creteur J , Sibbald W , Vincent J-L. 2000. Hemoglobin solutions - Not just red blood cell substitutes. Crit Care Med 28: 3025-3034.

16.

Drobin D , Hahn RG. 1999. Volume kinetics of Ringer’s solution in hypovolaemic volunteers. Anaesthesiology 90: 81-91.

17.

Evans PA , Glenn JR , Heptinstall S et al. 1998. Effects of gelatin-based resuscitation fluids on platelet aggregation. Br J Anaesth 81: 198-202.

18.

Gan TJ , Bennett-Guerrero E , Phillips-Bute B et al. 1999. Hextend®, a physiologically balanced plasma expander for large volume use in major surgery: a randomised phase III clinical trial. Anesth Analg 88: 992-998.

19.

Goodnough LT , Brecher ME , Kanter MH et al. 1999. Blood transfusion. N Engl J Med 340: 438-447.

20.

Goodwin CW , Dorethy J , Lam V et al. 1983. Randomised trial of efficacy of crystalloid and colloid resuscitation on hemo-dynamic response and lung water following thermal injury. Ann Surg 197: 520-531.

21.

Gould SA , Moore EE , Hoyt DB et al. 1998. The first randomised trial of human polymerised hemoglobin as a blood substitute in acute trauma and emergent surgery. J Am Coll Surg 187: 113-122.

22.

Guyton AC , Hall JE. 1996. The microcirculation and the lymph-atic system: capillary fluid exchange, interstitial fluid, and lymph flow. In: Guyton AC , Hall JE eds. Textbook of medical physiology. Philadelphia: WB Saunders: 183-196.

23.

Hahn RG , Svensén CH. 2000. Volume kinetics of fluids infused intravenously. Curr Anaesth Crit Care 11: 3-6.

24.

Haljamae H , Dahlqvist M , Walentin F. 1997. Artificial colloids in clinical practice: pros and cons. Baillière’s Clin Anaesth 11: 49-79.

25.

Hillman K , Bishop G , Bristow P. 1997. The crystalloid versus colloid controversy: present status. Baillière’s Clin Anaesth 11: 1-13.

26.

Hjelmqvist H. 2000. Colloids versus crystalloids. Curr Anaesth and Crit Care 11: 7-10.

27.

Hsia CCW. 1998. Respiratory function of haemoglobin. N Engl J Med 338: 239-247.

28.

Karoutsos S , Nathan N , Lahrimi A et al. 1999. Thromboelastogram reveals hypercoagulability after administration of gelatin solution. Br J Anaesth 82: 175-177.

29.

Kramer GC , Elgjo GI , Poli de Figueiredo LF et al. 1997. Hyper-osmotic-hyperoncotic solutions. Baillière’s Clin Anaesth 11: 143-160.

30.

Kreimeier U , Christ F , Kraft D et al. 1995. Anaphylaxis due to hydroxyethyl starch reactive antibodies. Lancet 346: 49-50.

31.

Laxenaire MC , Charpentier C , Feldman L. 1994. Anaphylactoid reactions to colloid plasma substitutes: incidence, risk factors, mechanisms. A French multicenter prospective study. Annales Francais d’Anesthesie et Reanimation 13: 301-310.

32.

Legendre C , Thervet E , Page B et al. 1993. Hydroxyethyl starch and osmotic-nephrosis-like lesions in kidney transplantation. Lancet 342: 248-249.

33.

Ljunström KG. 1997. Colloid safety: fact and fiction. Baillière’s Clin Anaesth 11: 163-177.

34.

Lowe RJ , Moss GS , Jilek J et al. 1977. Crystalloid vs. colloid in the etiology of pulmonary failure after trauma: a randomised trial in man. Surgery 81: 676-683.

35.

Mardel SN , Saunders FM , Allen H et al. 1998. Reduced quality of clot formation with gelatin-based plasma substitutes. Br J Anaesth 80: 204-207.

36.

Margarson MP , Soni N. 1998. Serum albumin: touchstone or totem? Anaesthesia 53: 789-803.

37.

McFarlane C , Lee A. 1994. A comparison of Plasmalyte 148 and 0.9% saline for intra-operative fluid replacement. Anaesthesia 49: 779-781.

38.

Metze D , Reimann S , Szepfalusi Z et al. 1997. Persistent pruritis after hydroxyethyl starch infusion therapy: a result of long term storage in cutaneous nerves. Br J Dermat 136: 553-559.

39.

Modig J. 1986. Effectiveness of dextran 70 versus Ringer’s acetate in traumatic shock and adult respiratory distress syndrome. Crit Care Med 14: 454-457.

40.

Nolan J. 1999. Fluid replacement. Brit Med Bull 55: 821-843.

41.

Nolan J. 2001. Fluid Resuscitation for the Trauma Patient. Resuscitation 48: 57-69.

42.

Petroianu GA , Liu J , Maleck WH et al. 2000. The effect of in vitro hemodilution with gelatin, dextran, hydroxyethyl starch, or Ringer’s solution on the thromboelastograph. Anesth Analg 90: 795-800.

43.

Prough DS. 1999. Hyperchloremic metabolic acidosis is a predictable consequence of intraoperative infusion of 0.9% saline. Anesthesiology 90: 1247-1249.

44.

Rackow EC , Falk JL , Fein A et al. 1983. Fluid resuscitation in circulatory shock: a comparison of the cardiorespiratory effects of albumin, hetastarch, and saline solutions in patients with hypovolaemic and septic shock. Crit Care Med 11: 839-850.

45.

Rocha e Silva M. 1997. Hypertonic saline resuscitation: a new concept. Baillière’s Clin Anaesth 11: 127-142.

46.

Saddler JM , Horsey PJ. 1987. The new generation gelatins. A review of their history, manufacture and properties. Anaesthesia 42: 998-1004.

47.

Scheingraber S , Rehm M , Sehmisch C et al. 1999. Rapid saline infusion produces hyperchloremic acidosis in patients undergoing gynecologic surgery. Anesthesiology 90: 1265-1270.

48.

Schierhout G , Roberts I. 1998. Fluid resuscitation with colloid or crystalloid solutions in critically ill patients: a systematic review of randomised trials. Br Med J 316: 961-964.

49.

Schmand JF , Ayala A , Morrison MH et al. 1995. Effects of hydroxyethyl starch after trauma-hemorrhagic shock: restoration of macrophage integrity and prevention of increasing circulating interleukin-6 levels. Crit Care Med 23: 806-814.

50.

Schortgen F , Lacherade J-C , Bruneel F et al. 2001. Effects of hydroxyethyl starch and gelatin on renal function in severe sepsis: a multicentre randomised study. Lancet 357: 911-916.

51.

Shires GT , Barber AE , Illner HP. 1995. Current status of resuscitation: solutions including hypertonic saline. Adv Surg 28: 133-170.

52.

Sirtl C , Laubenthal H , Zumtobel V et al. 1999. Tissue deposits of hydroxyethyl starch (HES): dose-dependent and time-related. Br J Anaesth 82: 510-515.

53.

Sloan EP , Koenigsberg M , Gens D et al. 1999. Diaspirin cross-linked hemoglobin (DCLHb) in the treatment of severe traumatic hemorrhagic shock. A randomised controlled efficacy trial. JAMA 282: 1857-1864.

54.

Soni N. 1995. Wonderful albumin? Br Med J 310: 887-888.

55.

Stockwell M , Soni N , Riley B. 1992. Colloid solutions in the critically ill. A randomised comparison of albumin and polyge-line. 1. Outcome and duration of stay in the intensive care unit. Anaesthesia 47: 3-6.

56.

Svensén C , Drobin D , Olsson J et al. 1999. Stability of the interstitial matrix after crystalloid loading by volume kinetic analysis. Br J Anaesth 82: 496-502.

57.

Svensén C , Ponzer S , Hahn RG. 1999. Volume kinetics of Ringer solution after surgery for hip fracture. Can J Anaesth 46: 133-141.

58.

Traylor RJ , Pearl RG. 1996. Crystalloid versus colloid versus colloid: all colloids are not created equal. Anesth Analg 83: 209-212.

59.

Treib J , Haass A , Pindur G et al. 1996a. All medium starches are not the same: influence of the degree of hydroxyethyl substitution of hydroxyethyl starch on plasma volume, hemorrheologic conditions, and coagulation. Transfusion 36: 450-455.

60.

Treib J , Haass A , Pindur G et al. 1996b. Influence of low molecular weight hydroxyethyl starch (HES 40/0.5-0.55) on hemostasis and hemorheology. Haemostasis 26: 258-265.

61.

Treib J , Haass A , Pindur G. 1997. Coagulation disorders caused by hydroxyethyl starch. Thromb Haemost 78: 974-983.

62.

Treib J , Baron J-F , Grauer MT et al. 1999. An international view of hydroxyethyl starches. Intensive Care Med 25: 258-268.

63.

Vassar MJ , Fischer RP , O’Brien PE et al. and the Multicenter Group for the Study of Hypertonic Saline in Trauma Patients . 1993. A multicenter trial for resuscitation of injured patients with 7.5% sodium chloride. Arch Surg 128: 1003-1013.

64.

Velanovich V. 1989. Crystalloid versus colloid fluid resuscitation: a meta-analysis of mortality. Surgery 105: 65-71.

65.

Vincent JL. 1991. Plugging the leaks? New insights into synthetic colloids. Crit Care Med 19: 316-317.

66.

Wade CE , Kramer GC , Grady JJ et al. 1997. Efficacy of hypertonic 7.5% saline and 6% dextran-70 in treating trauma: a meta-analysis of controlled clinical studies. Surgery 122: 609-616.

67.

Waschke KF , Frietsch T. 1999. Modified haemoglobins and perflurocarbons. Curr Opin Anaesthesiol 12: 195-202.

68.

Watenpaugh DE , Gaffney FA. 1998. Measurement of the net whole-body transcapillary fluid transport and effective vascular compliance in humans. J Trauma 45: 1062-1068.

69.

Webb AR , Tighe D , Moss RF et al. 1991. Advantages of a narrow range, medium molecular weight hydroxyethyl starch for volume maintenance in a porcine model of fecal peritonitis. Crit Care Med 19: 409-416.

70.

Whinney RR , Cohn SM , Zacur SJ. 2000. Fluid resuscitation for trauma patients in the 21st century. Curr Opin Crit Care 6: 395-400.

71.

Wilcox CS. 1983. Regulation of renal blood flow by plasma chloride. J Clin Invest 71: 726-735.

72.

Williams EL , Hildebrand KL , McCormick SA et al. 1999. The effect of intravenous lactated Ringer’s solution versus 0.9% sodium chloride solution on serum osmolality in human volunteers. Anesth Analg 88: 999-1003.

73.

Yentis SM , Hirsch NP , Smith GB , eds. 1995. Anaesthesia A to Z. Butterworth-Heinemann: 110-110.

74.

Zikria BA , King TC , Stanford J et al. 1989. A biophysical approach to capillary permeability. Surgery 105: 624-631.

75.

Zikria BA , Subbarao C , Oz MC et al. 1990. Hydroxyethyl starch macromolecules reduce myocardial reperfusion injury. Arch Surg 125: 930-934.

Which fluid to give?

Abstract

Keywords

Get full access to this article

References